{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:21:52Z","timestamp":1794374512175,"version":"4.9.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020256","name":"Medisinske fakultet, Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry Global Open Science"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bpsgos.2023.07.004","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T09:51:01Z","timestamp":1690105861000},"page":"594-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions"],"prefix":"10.1016","volume":"3","author":[{"given":"John Kim","family":"Hiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jangmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Steen","family":"Tesli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr Pawel","family":"Jaholkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Zsuzsanna","family":"Hoseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Haram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsgos.2023.07.004_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjpo.bp.115.002402","article-title":"Days out of role due to common physical and mental conditions in Portugal: Results from the WHO World Mental Health Survey","volume":"3","author":"Cardoso","year":"2017","journal-title":"BJPsych Open"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: A Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrn2513","article-title":"Why do many psychiatric disorders emerge during adolescence?","volume":"9","author":"Paus","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12888-014-0363-z","article-title":"Early risk factors for adult bipolar disorder in adolescents with mood disorders: A 15-year follow-up of a community sample","volume":"14","author":"P\u00e4\u00e4ren","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib9","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: Challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.mp.4001815","article-title":"Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: Supportive evidence for linkage at 3p14","volume":"11","author":"Etain","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng0595-8b","article-title":"Linkage findings in bipolar disorder","volume":"10","author":"Gurling","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1176\/appi.ajp.2014.14010035","article-title":"Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: A longitudinal study","volume":"172","author":"Axelson","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2004.04.010","article-title":"Aberration of cholesterol level in first-onset bipolar I patients","volume":"83","author":"Pae","year":"2004","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2007.08.021","article-title":"Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder","volume":"160","author":"Mcnamara","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.dsx.2015.04.004","article-title":"Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder","volume":"9","author":"Wysoki\u0144ski","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","article-title":"Side effects of atypical antipsychotics: A brief overview","volume":"7","author":"\u00dc\u00c7OK","year":"2008","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2013 Pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11064-010-0195-2","article-title":"Role of oxidative stress in the pathophysiology of bipolar disorder","volume":"35","author":"Steckert","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.940","article-title":"Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder","volume":"20","author":"Kuloglu","year":"2002","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0091217417749786","article-title":"State-dependent alterations of lipid profiles in patients with bipolar disorder","volume":"53","author":"Huang","year":"2018","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5560453","article-title":"Increased global-brain functional connectivity is associated with dyslipidemia and cognitive impairment in first-episode, drug-naive patients with bipolar disorder","volume":"2021","author":"Pan","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/medicina57010028","article-title":"Lipid and glycemic profiles in patients with bipolar disorder: Cholesterol levels are reduced in mania","volume":"57","author":"Fusar-Poli","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/ijamh-2013-0002","article-title":"Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia","volume":"25","author":"Enger","year":"2013","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib25","doi-asserted-by":"crossref","first-page":"pyu101","DOI":"10.1093\/ijnp\/pyu101","article-title":"Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects","volume":"18","author":"Munkholm","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: Is arachidonic acid a nexus in the pathophysiology of schizophrenia?","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/mp.2016.259","article-title":"A\u00a0genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder","volume":"23","author":"Ikeda","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41398-021-01527-z","article-title":"Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes","volume":"11","author":"R\u00f8devand","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.euroneuro.2016.07.011","article-title":"Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment","volume":"27","author":"Steen","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.04.047","article-title":"Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"200","author":"Salagre","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2019.07.002","article-title":"Do statins have an effect on depressive symptoms? A systematic review and meta-analysis","volume":"257","author":"Yatham","year":"2019","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12888-014-0348-y","article-title":"Statin use and risk of depression: A Swedish national cohort study","volume":"14","author":"Redlich","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41398-023-02403-8","article-title":"Investigating the potential anti-depressive mechanisms of statins: A transcriptomic and Mendelian randomization analysis","volume":"13","author":"Jiang","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","article-title":"The new field of \u2018precision psychiatry.\u2019","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpsychires.2017.05.009","article-title":"Schizophrenia: A review of potential biomarkers","volume":"93","author":"Rodrigues-Amorim","year":"2017","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0269881114566631","article-title":"Schizophrenia biomarkers: Translating the descriptive into the diagnostic","volume":"29","author":"Pickard","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib37","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1017\/S0033291716000957","article-title":"Bias in emerging biomarkers for bipolar disorder","volume":"46","author":"Carvalho","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","article-title":"A\u00a0systematic review of metabolite biomarkers of schizophrenia","volume":"195","author":"Davison","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737175.2019.1550361","article-title":"Biomarkers for bipolar disorder: Current status and challenges ahead","volume":"19","author":"Teixeira","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pcn.12476","article-title":"Biological hypotheses and biomarkers of bipolar disorder","volume":"71","author":"Sigitova","year":"2017","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: Role of inflammation and the development of disease biomarkers","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib43","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/pr800188y","article-title":"High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides","volume":"7","author":"Schwarz","year":"2008","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","article-title":"A\u00a0preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics","volume":"258","author":"Ribeiro","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41398-020-01080-1","article-title":"Lipidomics of the brain, retina, and biofluids: From the biological landscape to potential clinical application in schizophrenia","volume":"10","author":"Zhuo","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/pcn.13194","article-title":"Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study","volume":"75","author":"Liu","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1440-1614.2001.01021.x","article-title":"Implications of lipid biology for the pathogenesis of schizophrenia","volume":"36","author":"Berger","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib49","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.bbalip.2014.12.014","article-title":"Brain membrane lipids in major depression and anxiety disorders","volume":"1851","author":"M\u00fcller","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/healthcare5010005","article-title":"The role of lipid biomarkers in major depression","volume":"5","author":"Parekh","year":"2017","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fpsyt.2018.00459","article-title":"Lipidomics in major depressive disorder","volume":"9","author":"Walther","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib54","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib55","author":"Hiller"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib59","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2075","article-title":"Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study","volume":"11","author":"Kageyama","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135515","article-title":"Metabolomic analysis to detect urinary molecular changes associated with bipolar depression","volume":"742","author":"Ren","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067809","article-title":"Serum leptin and cholesterol levels in patients with bipolar disorder","volume":"46","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.717824","article-title":"Metabolic syndrome impairs executive function in bipolar disorder","volume":"15","author":"Dalkner","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/039463200802100208","article-title":"Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder","volume":"21","author":"De Berardis","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1744-859X-9-36","article-title":"Lower paraoxonase 1 activity in Tunisian bipolar I patients","volume":"9","author":"Ezzaher","year":"2010","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib66","first-page":"1","article-title":"Associations and limited shared genetic aetiology between bipolar disorder and cardiometabolic traits in the UK Biobank","volume":"52","author":"F\u00fcrtjes","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-5618.2000.020109.x","article-title":"Cholesterol levels in mood disorders: High or low?","volume":"2","author":"Ghaemi","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000441-199430840-00002","article-title":"Hypocholesterolemia and affective disorders","volume":"308","author":"Glueck","year":"1994","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105902","article-title":"Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder","volume":"211","author":"Guidara","year":"2021","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s12031-022-02000-2","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) levels in adolescent with bipolar disorder and their relationship with metabolic parameters","volume":"72","author":"Kasak","year":"2022","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/acps.13278","article-title":"Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder","volume":"143","author":"Kennedy","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpsychires.2016.08.019","article-title":"Impulsivity is associated with blood pressure and waist circumference among adolescents with bipolar disorder","volume":"83","author":"Naiberg","year":"2016","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/acps.12603","article-title":"Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder","volume":"134","author":"Naiberg","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2014.09.038","article-title":"Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder","volume":"172","author":"Nunes","year":"2015","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib75","article-title":"Comparison of the severity of depressive and anxiety symptoms, biomarkers, and childhood trauma among bipolar smokers and non-smokers, and controls","volume":"8","author":"Porcu","year":"2022","journal-title":"J\u00a0Affect Disord Rep"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jad.2021.10.100","article-title":"Association between abnormal glycolipid level and cognitive dysfunction in drug-naive patients with bipolar disorder","volume":"297","author":"Qiu","year":"2022","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.05.030","article-title":"Platelet serotonin and serum lipids in psychotic mania","volume":"97","author":"Sagud","year":"2007","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2008.06.048","article-title":"Lipid levels in female patients with affective disorders","volume":"168","author":"Sagud","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s10020-019-0119-9","article-title":"Comparison of blood lipid profile\/thyroid function markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts","volume":"25","author":"Su","year":"2019","journal-title":"Mol Med"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib80","volume":"13","author":"Wei","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib81","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/bdi.12633","article-title":"Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder","volume":"20","author":"Wulsin","year":"2018","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpsychires.2014.06.001","article-title":"Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism","volume":"57","author":"Evans","year":"2014","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2015.06.001","article-title":"Plasma linoleic acid partially mediates the association of bipolar disorder on self-reported mental health scales","volume":"68","author":"Evans","year":"2015","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41398-019-0536-0","article-title":"Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder","volume":"9","author":"Koga","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/eip.12282","article-title":"Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker","volume":"10","author":"McNamara","year":"2016","journal-title":"Early Interv Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.psychres.2016.10.042","article-title":"Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits","volume":"246","author":"McNamara","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib88","doi-asserted-by":"crossref","first-page":"e1301","DOI":"10.4088\/JCP.15r09925","article-title":"Omega-3 and Omega-6 polyunsaturated fatty acids in bipolar disorder: A review of biomarker and treatment studies","volume":"77","author":"Saunders","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jpsychires.2012.11.004","article-title":"Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA","volume":"47","author":"Pomponi","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib90","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00406-018-0897-z","article-title":"Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders","volume":"269","author":"Gohar","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ijnp\/pyx089","article-title":"Plasma nervonic acid is a potential biomarker for major depressive disorder: A pilot study","volume":"21","author":"Kageyama","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib92","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1399-5618.2007.00387.x","article-title":"Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania","volume":"9","author":"Sublette","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/hm.hm_24_19","article-title":"Inflammatory and vascular correlates of mood change over 8 weeks","volume":"3","author":"Birdsall","year":"2019","journal-title":"Heart Mind (Mumbai)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib94","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1440-1819.2007.01689.x","article-title":"Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan","volume":"61","author":"Chung","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib95","article-title":"Childhood trauma, interleukin-17, C-reactive protein, metabolism, and psychosocial functioning in bipolar depression","volume":"9","author":"Congio","year":"2022","journal-title":"J\u00a0Affect Disord Rep"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00406-009-0013-5","article-title":"Metabolic syndrome: A follow-up study of acute depressive inpatients","volume":"260","author":"Richter","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib97","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11745-008-3224-z","article-title":"Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder","volume":"43","author":"Clayton","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib98","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00406-002-0367-4","article-title":"Hypocholesterolemia during mixed manic episodes","volume":"252","author":"Cassidy","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/24750573.2018.1471882","article-title":"Serum 15-d-PGJ2 and PPARgamma levels are reduced in manic episode of bipolar disorder while IL-4 levels are not affected","volume":"29","author":"Erzin","year":"2019","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0924-977X(02)00130-X","article-title":"Polyunsaturated fatty acid deficit in patients with bipolar mania","volume":"13","author":"Chiu","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib101","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jpsychires.2012.07.016","article-title":"Association of plasma omega-3 and omega-6 lipids with burden of disease measures in bipolar subjects","volume":"46","author":"Evans","year":"2012","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/13651501.2014.988271","article-title":"The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders","volume":"19","author":"Shakeri","year":"2015","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fpsyt.2019.00070","article-title":"The association between dyslipidemia and lethality of suicide attempts: A case-control study","volume":"10","author":"Aguglia","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib104","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/neu.2014.18","article-title":"Suicidal behaviour and lipid levels in unipolar and bipolar depression","volume":"26","author":"Ainiyet","year":"2014","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jad.2014.10.033","article-title":"Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders","volume":"172","author":"da Gra\u00e7a Cantarelli","year":"2015","journal-title":"J\u00a0Affect Disord"},{"issue":"suppl 2","key":"10.1016\/j.bpsgos.2023.07.004_bib106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/S0924270800032798","article-title":"Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts","volume":"21","author":"Vuksan-\u0106usa","year":"2009","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5717445","article-title":"Metabolomic identification of serum exosome-derived biomarkers for bipolar disorder","volume":"2022","author":"Du","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib108","article-title":"Alterations in the plasma lipidome of adult women with bipolar disorder: A mass spectrometry-based lipidomics research","volume":"13","author":"Guo","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib109","article-title":"Alterations of plasma lipids in adult women with major depressive disorder and bipolar depression","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2019.04.002","article-title":"Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder","volume":"95","author":"Brunkhorst-Kanaan","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11306-022-01924-5","article-title":"Metabolomic and proteomic profiling in bipolar disorder patients revealed potential molecular signatures related to hemostasis","volume":"18","author":"Ribeiro","year":"2022","journal-title":"Metabolomics"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2021.100045","article-title":"Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis","volume":"5","author":"Avigdor","year":"2021","journal-title":"Biomark Neuropsychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jpsychires.2009.08.001","article-title":"Brain lipid concentrations in bipolar disorder","volume":"44","author":"Igarashi","year":"2010","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib114","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1192\/bjp.169.6.682","article-title":"Cholesterol and mental disorder","volume":"169","author":"Boston","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.312.7025.221","article-title":"Low serum cholesterol concentration and serotonin metabolism in men","volume":"312","author":"Steegmans","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib116","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-0327(99)00200-1","article-title":"Cholesterol and serotonin indices in depressed and suicidal patients","volume":"62","author":"Sarchiapone","year":"2001","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib117","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1021\/bi010730z","article-title":"Membrane cholesterol modulates serotonin transporter activity","volume":"40","author":"Scanlon","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib118","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jmb.2019.02.030","article-title":"Influence of cholesterol and its stereoisomers on members of the serotonin receptor family","volume":"431","author":"Oakes","year":"2019","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib119","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2015.00222","article-title":"Antioxidant properties of HDL","volume":"6","author":"Soran","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.genhosppsych.2009.04.002","article-title":"The longitudinal effects of depression on physical activity","volume":"31","author":"Roshanaei-Moghaddam","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib122","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2009.04.018","article-title":"The quantitative assessment of motor activity in mania and schizophrenia","volume":"120","author":"Minassian","year":"2010","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib124","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","author":"Tschoner","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib125","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cell.2010.11.033","article-title":"Lipidomics: New tools and applications","volume":"143","author":"Wenk","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib127","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15622975.2022.2111713","article-title":"Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?","volume":"24","author":"Topuz","year":"2022","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J\u00a0Am Coll Nutr"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar disorder and inflammation","volume":"39","author":"Rosenblat","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","article-title":"Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders","volume":"106","author":"Farooqui","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib133","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1096\/fasebj.11.1.9034165","article-title":"Lipid biochemistry: Functions of glycerolipids and sphingolipids in cellular signaling","volume":"11","author":"Ghosh","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mas.21627","article-title":"High resolution mass spectrometry in lipidomics","volume":"40","author":"Z\u00fcllig","year":"2021","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib136","first-page":"e1229","article-title":"Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer","volume":"2","author":"Holzlechner","year":"2019","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/jms.4400","article-title":"Lipid mass spectrometry: A path traveled for 50 years","volume":"55","author":"Murphy","year":"2020","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib138","article-title":"Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: Evidence from the RAPIDO randomised controlled trial","volume":"11","author":"Dixon","year":"2021","journal-title":"BMJ (Open)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib139","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s42255-019-0094-z","article-title":"Lipidomics needs more standardization","volume":"1","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib140","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbalip.2017.02.008","article-title":"Lipidomics, en route to accurate quantitation","volume":"1862","author":"Lam","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib141","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","article-title":"Associations between plasma fatty acid concentrations and schizophrenia: A two-sample Mendelian randomisation study","volume":"8","author":"Jones","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073076","article-title":"The human urine metabolome","volume":"8","author":"Bouatra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib143","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dadm.2017.04.007","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib144","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bdi.12874","article-title":"More on the NIMH RDoC initiative","volume":"22","author":"Greenebaum","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib146","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2018.01.014","article-title":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: An exploratory pilot case-control study","volume":"231","author":"Kuwano","year":"2018","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib147","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/acps.13305","article-title":"Serum lipids and suicidal risk among patients with schizophrenia spectrum disorders: Systematic review and meta-analysis","volume":"144","author":"Sankaranarayanan","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243847","article-title":"Association between serum lipid concentrations and attempted suicide in patients with major depressive disorder: A meta-analysis","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bpsgos.2023.07.004_bib149","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1176\/jnp.2006.18.3.296","article-title":"Bipolar disorder: Imaging state versus trait","volume":"18","author":"Friedman","year":"2006","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"}],"container-title":["Biological Psychiatry Global Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266717432300085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266717432300085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:28:51Z","timestamp":1794371331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266717432300085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S266717432300085X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsgos.2023.07.004","relation":{},"ISSN":["2667-1743"],"issn-type":[{"value":"2667-1743","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry Global Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsgos.2023.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of the Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}